Tesaro Antitrust Filings
It looks like all of the required antitrust filings for GlaxoSmithKline’s acquisition of Tesaro has been completed:
1. US Antitrust (HSR) filed on 12/14/18 with an
expiration of 12/31/18
2. German Antitrust (FCO) filed on 12/18/18 with an
expiration of 1/18/19
3. Austrian Antitrust (FCA) filed on 12/18/18 with an
expiration of 1/15/19
The tender offer expires on 1/14/19, which I see as a high likelihood
of occurring. Could possibly see a tender extension based on the time frame in
the completion of the FCO and FCA antitrust reviews. The spread has widened a
bit, which is likely attributed to the overall market. Lots of other arb
spreads have started widening a bit as players are in a risk off mentality.